ES2180643T3 - Procedimiento para tratar la disfuncion cognitiva. - Google Patents

Procedimiento para tratar la disfuncion cognitiva.

Info

Publication number
ES2180643T3
ES2180643T3 ES95922148T ES95922148T ES2180643T3 ES 2180643 T3 ES2180643 T3 ES 2180643T3 ES 95922148 T ES95922148 T ES 95922148T ES 95922148 T ES95922148 T ES 95922148T ES 2180643 T3 ES2180643 T3 ES 2180643T3
Authority
ES
Spain
Prior art keywords
procedure
cognitive dysfunction
treat cognitive
methyl
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95922148T
Other languages
English (en)
Inventor
Charles M Beasley Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority claimed from CA002219902A external-priority patent/CA2219902A1/en
Application granted granted Critical
Publication of ES2180643T3 publication Critical patent/ES2180643T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Processing Of Meat And Fish (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION PROPORCIONA UN METODO PARA TRATAR UNA DISFUNCION COGNITIVA QUE COMPRENDE LA ADMINISTRACION DE UNA CANTIDAD EFECTIVA DE 2
ES95922148T 1995-05-30 1995-05-30 Procedimiento para tratar la disfuncion cognitiva. Expired - Lifetime ES2180643T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002219902A CA2219902A1 (en) 1995-05-30 1995-05-30 Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno¬2,3b|¬1,5|benzodiazepine for treating cognitive dysfunction
PCT/US1995/006859 WO1996038151A1 (en) 1995-05-30 1995-05-30 Method for treating cognitive dysfunction

Publications (1)

Publication Number Publication Date
ES2180643T3 true ES2180643T3 (es) 2003-02-16

Family

ID=25679786

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95922148T Expired - Lifetime ES2180643T3 (es) 1995-05-30 1995-05-30 Procedimiento para tratar la disfuncion cognitiva.

Country Status (17)

Country Link
EP (1) EP0828494B1 (es)
JP (1) JPH11506096A (es)
AT (1) ATE220550T1 (es)
AU (1) AU707858B2 (es)
CZ (1) CZ292565B6 (es)
DE (1) DE69527442T2 (es)
DK (1) DK0828494T3 (es)
ES (1) ES2180643T3 (es)
FI (1) FI973987A (es)
HK (1) HK1009393A1 (es)
HU (1) HUT77907A (es)
MX (1) MX9707936A (es)
NO (1) NO318553B1 (es)
NZ (1) NZ288037A (es)
PL (1) PL189714B1 (es)
PT (1) PT828494E (es)
WO (1) WO1996038151A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
UA57727C2 (uk) * 1996-03-11 2003-07-15 Елі Ліллі Енд Компані Спосіб лікування надмірної агресивності
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
WO2005070938A1 (en) 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
US7932249B2 (en) 2005-01-05 2011-04-26 Eli Lilly And Company Olanzapine pamoate dihydrate
PL381564A1 (pl) 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270464A (en) * 1989-03-14 1993-12-14 Janssen Pharmaceutica N.V. Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
AU707858B2 (en) 1999-07-22
DE69527442D1 (de) 2002-08-22
DE69527442T2 (de) 2003-02-20
EP0828494A4 (en) 1999-11-24
MX9707936A (es) 1997-12-31
PL189714B1 (pl) 2005-09-30
HUT77907A (hu) 1998-10-28
EP0828494A1 (en) 1998-03-18
NO318553B1 (no) 2005-04-11
FI973987A0 (fi) 1997-10-17
WO1996038151A1 (en) 1996-12-05
FI973987A (fi) 1997-10-17
PT828494E (pt) 2002-10-31
NO974766D0 (no) 1997-10-15
AU2693695A (en) 1996-12-18
JPH11506096A (ja) 1999-06-02
NZ288037A (en) 1999-09-29
HK1009393A1 (en) 1999-06-04
NO974766L (no) 1997-12-09
DK0828494T3 (da) 2002-09-02
ATE220550T1 (de) 2002-08-15
CZ324397A3 (cs) 1998-08-12
EP0828494B1 (en) 2002-07-17
PL323785A1 (en) 1998-04-27
CZ292565B6 (cs) 2003-10-15

Similar Documents

Publication Publication Date Title
MY114701A (en) Process and crystal forms of 2-methyl-thieno- benzodiazepine
NO178766C (no) Analogifremgangsmåte for fremstilling av benzodiazepin og mellomprodukter derav
WO2000002546A3 (en) Use of caba-analogues for treating insomnia
DE60336226D1 (de) Verfahren zur herstellung von olanzapin form i
IL117971A0 (en) Method for treating dyskinesias
NZ510208A (en) Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) pamoate salt
EP0735054A3 (en) Process for the treatment of modified polymers
ES2180643T3 (es) Procedimiento para tratar la disfuncion cognitiva.
BR9605030A (pt) Processo para derivados de 4H-imidazol [1, 5-a][1, 4] benzodiazepina
NO982911L (no) FremgangsmÕte for behandling av depresjon
NZ332037A (en) Olanzapine for treating migraine pain
EP0911028A3 (en) Method for treating sexual dysfunction
TW429149B (en) Pharmaceutical composition for treating conditions resulting from the cessation and withdrawal from the use of nicotine
PT831835E (pt) Metodo para tratamento da anorexia
ZA976854B (en) Treatment of psychotic disorders.
NZ324615A (en) Method for treating autism using olanzapine
HUP9902882A2 (hu) Olanzapin alkalmazása álmatlanság kezelésére szolgáló gyógyszerkészítmények előállítására
NZ331846A (en) Method for preparing a medicament using olanzapine for treating insomnia
ES1033530Y (es) Aparato para depurar aguas residuales.
HUT76738A (en) Method for treating of high fat contain waters
HUT76735A (en) Method for treatment of sludges
ZA966815B (en) Method of treating water.
MX9606562A (es) Procedimiento para eliminacion de colorante.